科兴制药: management transactions · France · AMF SSE:688136 FR FR · AMF Mcap 6.4Bn€
Browse the full directors' dealings record of 科兴制药, a listed equity based in France. Shares are listed on FR FR, under the oversight of AMF. Market capitalisation: €6.4bn. The latest transaction was filed on 19 September 2025 (Sale). Among the most active insiders: 邓学勤. Every trade is free.
Financial data FY ended December 2025 · cache
Income statement
Revenue 1.53 Bn€
Gross profit 972.1 M€ 63% margin
Net income 155.6 M€ 10.1% margin
Balance sheet & cash
Market cap 6.37 Bn€
Total debt 1.40 Bn€
Free Cash Flow 2.4 M€
Last declaration on 19 September 2025
Declarations 6 total
Executives ● Sale22 SSE
10,062,800 shares
SSE:173000009556952350 · 19 Sept 2025
Executives ● Purchase7 SSE
22,397 shares
SSE:173000006628061440 · 30 May 2023
Ideal exit: 24 Feb 2024 (T+270) Executives ● Purchase7 SSE
44,235 shares
SSE:173000006618638820 · 25 May 2023
Ideal exit: 19 Feb 2024 (T+270) Executives ● Purchase7 SSE
50,800 shares
SSE:173000006614201280 · 23 May 2023
Ideal exit: 17 Feb 2024 (T+270) Executives ● Purchase7 SSE
50,000 shares
SSE:173000006614257760 · 22 May 2023
Ideal exit: 16 Feb 2024 (T+270) Executives ● Purchase7 SSE
10,800 shares
SSE:173000006601808220 · 17 May 2023
Ideal exit: 11 Feb 2024 (T+270)